[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BE903693A - Derives de flavolignanes, procedes pour leur preparation et medicaments contenant ces composes. - Google Patents

Derives de flavolignanes, procedes pour leur preparation et medicaments contenant ces composes.

Info

Publication number
BE903693A
BE903693A BE2/60850A BE2060850A BE903693A BE 903693 A BE903693 A BE 903693A BE 2/60850 A BE2/60850 A BE 2/60850A BE 2060850 A BE2060850 A BE 2060850A BE 903693 A BE903693 A BE 903693A
Authority
BE
Belgium
Prior art keywords
flavolignan
derivatives
compounds
processes
preparation
Prior art date
Application number
BE2/60850A
Other languages
English (en)
Inventor
R Braatz
K Gorler
G Halbach
H Soicke
K Schmidt
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of BE903693A publication Critical patent/BE903693A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)

Abstract

Les dérivés de la silibinine répondant à la formule générale ci-dessous, dans laquelle n et m = O ou 1; Alk1 et Alk2 = alcoylène en C1-C4 ou alcènylène en C2-C4 et M1 et M2 = H ou métal alcalin, sont des médicaments utiles notamment pour le traitement des lésions par brulures, des cirrhoses du foie et d'autres troubles toxiques-métaboliques du foie ainsi que des empoisonnements par des champignons.
BE2/60850A 1984-11-22 1985-11-22 Derives de flavolignanes, procedes pour leur preparation et medicaments contenant ces composes. BE903693A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Publications (1)

Publication Number Publication Date
BE903693A true BE903693A (fr) 1986-05-22

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2/60850A BE903693A (fr) 1984-11-22 1985-11-22 Derives de flavolignanes, procedes pour leur preparation et medicaments contenant ces composes.

Country Status (29)

Country Link
JP (1) JPS61143377A (fr)
KR (1) KR870001020B1 (fr)
AR (1) AR240931A1 (fr)
AT (1) AT393268B (fr)
BE (1) BE903693A (fr)
CA (1) CA1337124C (fr)
CH (1) CH659473A5 (fr)
CS (1) CS273610B2 (fr)
DD (1) DD259191A1 (fr)
DE (1) DE3442639A1 (fr)
DK (1) DK164865C (fr)
EG (1) EG19424A (fr)
ES (1) ES8609311A1 (fr)
FI (1) FI84064C (fr)
FR (1) FR2573427B1 (fr)
GB (1) GB2167414B (fr)
HU (1) HU195503B (fr)
IE (1) IE58791B1 (fr)
IT (1) IT1190426B (fr)
LU (1) LU86163A1 (fr)
MX (1) MX168415B (fr)
NL (1) NL192387C (fr)
NO (1) NO160205C (fr)
PL (1) PL146890B1 (fr)
PT (1) PT81532B (fr)
SE (1) SE465676B (fr)
SU (1) SU1436875A3 (fr)
YU (1) YU43689B (fr)
ZA (1) ZA858951B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
CA2601028C (fr) * 2005-03-11 2014-05-27 Howard Florey Institute Of Experimental Physiology And Medecine Composes flavonoides et utilisations correspondantes
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
EP2392326B9 (fr) * 2007-11-15 2018-09-05 Madaus GmbH Composant de la Silibinine pour le traitement de l'hépatite
WO2010130460A1 (fr) * 2009-05-14 2010-11-18 Euromed S.A. Silibinine amorphe pour le traitement d'une hépatite virale
AU2013286721B2 (en) 2012-07-05 2018-04-26 Nutramax Laboratories, Inc. Compositions comprising a sulforaphane or a sulforaphane precursor and milk thistle extract or powder
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
IE58791B1 (en) 1993-11-17
FI84064B (fi) 1991-06-28
FR2573427A1 (fr) 1986-05-23
PT81532A (de) 1985-12-01
NO160205C (no) 1989-03-22
SE8505487L (sv) 1986-05-23
CS273610B2 (en) 1991-03-12
NO160205B (no) 1988-12-12
YU178685A (en) 1988-02-29
SE8505487D0 (sv) 1985-11-20
DE3442639A1 (de) 1986-05-22
HU195503B (en) 1988-05-30
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
LU86163A1 (de) 1986-03-24
YU43689B (en) 1989-10-31
NL192387C (nl) 1997-07-04
EG19424A (en) 1995-02-28
MX168415B (es) 1993-05-24
ES549116A0 (es) 1986-09-01
KR860004056A (ko) 1986-06-16
NL192387B (nl) 1997-03-03
AR240931A2 (es) 1991-03-27
PL256374A1 (en) 1986-12-02
ZA858951B (en) 1986-08-27
IE852808L (en) 1986-05-22
PT81532B (pt) 1987-11-11
GB2167414A (en) 1986-05-29
IT1190426B (it) 1988-02-16
JPS61143377A (ja) 1986-07-01
AR240931A1 (es) 1991-03-27
DK537785D0 (da) 1985-11-21
KR870001020B1 (ko) 1987-05-23
DK537785A (da) 1986-05-23
FI854535A0 (fi) 1985-11-18
CA1337124C (fr) 1995-09-26
IT8522932A0 (it) 1985-11-21
JPH0432073B2 (fr) 1992-05-28
DE3442639C2 (fr) 1989-08-10
AT393268B (de) 1991-09-25
SU1436875A3 (ru) 1988-11-07
CS837885A2 (en) 1990-08-14
FI854535A (fi) 1986-05-23
NO854655L (no) 1986-05-23
DD259191A1 (de) 1988-08-17
HUT40114A (en) 1986-11-28
FI84064C (fi) 1991-10-10
NL8503171A (nl) 1986-06-16
DK164865C (da) 1993-01-18
ES8609311A1 (es) 1986-09-01
GB8528226D0 (en) 1985-12-18
DK164865B (da) 1992-08-31
FR2573427B1 (fr) 1989-03-10
ATA337185A (de) 1991-02-15
CH659473A5 (de) 1987-01-30
GB2167414B (en) 1989-01-11

Similar Documents

Publication Publication Date Title
EP0254067A3 (fr) Composition pour la prévention de la métastase
BE904368A (fr) Nouveaux derives de pyridylmethoxy- et methylmercaptoanilines, utiles notamment comme antiasthmatiques, leur fabrication et medicaments les contenant.
LV12766A (lv) Composition of l-dopa esters
BE903693A (fr) Derives de flavolignanes, procedes pour leur preparation et medicaments contenant ces composes.
BE899564A (fr) Composition pharmaceutique pour l'administration parenterale a base de nimodipin et procede pour sa preparation.
BE903183A (fr) Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant
HUP0302635A2 (hu) Valpronsav foszfolipidszármazékai és ezek keveréke
FR2554346B1 (fr) Ensemble et procede pour l'administration de gangliosides et de leurs derives par inhalation et compositions pharmaceutiques les contenant
KR20010031407A (ko) 소화기관 질환 치료제로 사용되는 쿠마린 유도체
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
KR900013969A (ko) 지루를 감소시키는 약학 조성물의 제조에 있어서 5'-데옥시-5'-메틸티오아데노신, s-아데노실메티오닌 및 이들의 염의 용도 및 이와 관련된 약학 조성물
ATE101138T1 (de) Parabansaeure-derivate und pharmazeutische zusammensetzungen damit.
FR2420346A1 (fr) Medicaments contenant des alcenylxanthines et leur procede de preparation
FR2446829A1 (fr) Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
CA2078869A1 (fr) Compositions pharmaceutiques contenant de l'ipriflavone, leur procede de preparation et leur emploi therapeutique relatif
BE900138A (fr) Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques.
KR890004705A (ko) 항바이러스성 제제
KR930019212A (ko) 피소스티그민 유도체와 이의 용도 및 이를 함유한 제약적 조제물
FR2383176A1 (fr) Amino aryl triazines 1-2-4 utilisables dans le traitement d'algies diverses
BE900780A (fr) DERIVES DE LA CHLORO-4-FURO (3,4-c)-PYRIDINE, LEUR PROCEDE DE PREPARATION ET COMPOSITIONS THERAPEUTIQUES A BASE DE CES DERIVES.
OA08165A (fr) Nouveaux dérivés thiosulfonates, leur procédé de préparation ainsi que les compositions pharmaceutiques les contenant.
BE904864A (fr) Derives de la quinoleine, leur procede de preparation et compositions pharmaceutiques les contenant.
KR950703955A (ko) 테르피리딘 유도체의 약학적 용도
BE904605A (fr) Hydroxy-1 acyloxy-8 acyl-10 anthrones, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique.
BE1000719A4 (fr) Derives de 3-(hydroxymethyl)-isoquinoleine, procede pour les preparer et compositions pharmaceutiques les contenant.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: DR. MADAUS G.M.B.H. & CO.

Effective date: 20011130